Results 291 to 300 of about 79,270 (300)

Physical examination of the female cancer patient with sexual concerns: What oncologists and patients should expect from consultation with a specialist

Ca-A Cancer Journal for Clinicians, 2016
Stacy Tessler Lindau, Emily M Abramsohn, Anuja Jhingran   +2 more
exaly  

Risk of ovarian function recovery should be considered when switching from treatment with adjuvant tamoxifen to aromatase inhibitor therapy in women with chemotherapy-induced amenorrhea

Ca-A Cancer Journal for Clinicians, 2018
Clement Chung
exaly  

Preserving Fertility After Cancer

Ca-A Cancer Journal for Clinicians, 2005
Carolyn D Runowicz
exaly  

The Effect of Provider Case Volume on Cancer Mortality: Systematic Review and Meta-Analysis

Ca-A Cancer Journal for Clinicians, 2009
exaly  

Cancer screening with multicancer detection tests: A translational science review

Ca-A Cancer Journal for Clinicians
Wendy S Rubinstein, Christos Patriotis
exaly  

The evolving landscape of tissue‐agnostic therapies in precision oncology

Ca-A Cancer Journal for Clinicians
Vivek Subbiah, Bettina Ryll, Razelle Kurzrock   +2 more
exaly  

Elucidation of Phosphodiesterase Type 5 Inhibitor Mechanism of Action

Journal of Urology, 2013
openaire   +2 more sources

Phosphodiesterase type 5 inhibitor therapy for priapism

2008
openaire   +1 more source

Tadalafil: Long-acting phosphodiesterase type 5 inhibitor

2008
openaire   +1 more source

Amlodipine/Selexipag/Type-5-cyclic-nucleotide-phosphodiesterase-inhibitors

Reactions Weekly
openaire   +1 more source